We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
4 hedge funds and large institutions have $239K invested in Windtree Therapeutics in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
23% more capital invested
Capital invested by funds: $194K → $239K (+$44.7K)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
33% less funds holding
Funds holding: 6 → 4 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$258K |
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$98.2K |
| 2 |
VF
Virtu Financial
New York
|
-$28K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$11.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$382 |
| 5 |
Morgan Stanley
New York
|
-$2 |